Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
38.06
+0.04 (0.11%)
Sep 4, 2026, 3:00 PM CST
| Market Cap | 12.12B -24.5% |
| Revenue (ttm) | 2.89B +1.5% |
| Net Income | 978.57M -1.7% |
| EPS | 3.06 -1.1% |
| Shares Out | 318.32M |
| PE Ratio | 12.46 |
| Forward PE | n/a |
| Dividend | 1.76 (4.62%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | 3,172,431 |
| Open | 38.08 |
| Previous Close | 38.02 |
| Day's Range | 37.90 - 38.49 |
| 52-Week Range | 34.80 - 57.98 |
| Beta | 0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |